What to do: If you have an allergy to milk, do not consume the recalled products
Audience: General public
Recall class: Class 1
Affected products
Brand
Product
Size
UPC
Codes
Searay
Sauerkraut Fish (Szechuan Style) Spicy
400 g
8 27510 00494 2
Best Before: 2022 JL 02 Lot number: 2101181CHG
Searay
Sauerkraut Fish (Golden Soup)
400 g
8 27510 00493 5
Best Before: 2022 JN 15 Lot number: 2012202CHG
Best Before: 2022 JL 02 Lot number: 2101182CHG
Issue
The recall notification issued on February 4, 2022, has been updated to a Food Recall Warning due to additional information. This additional information was identified during the Canadian Food Inspection Agency's food safety investigation.
Searay Foods Inc. is recalling Searay brand Sauerkraut Fish (Szechuan Style) Spicy and Sauerkraut Fish (Golden Soup) from the marketplace because they may contain milk which is not declared on the label.
The recalled products have been sold in Alberta, British Columbia, Manitoba, Nova Scotia, Ontario, Quebec, and Saskatchewan and may have been distributed in other provinces and territories.
What you should do
Check to see if you have the recalled products in your home
If you have an allergy to milk, do not consume the recalled products as they may cause a serious or life-threatening reaction
Recalled products should be thrown out or returned to the location where they were purchased
This recall was triggered by Canadian Food Inspection Agency test results.
There have been no reported reactions associated with the consumption of these products.
What is being done
The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated food recall warnings.
The CFIA is verifying that industry is removing the recalled products from the marketplace.
Anonybit announced today a significant upgrade to its Decentralized Data Vault offering, enabling support for an expanded range of use cases across the identity management lifecycle. The Anonybit Decentralized Data Vault builds upon the company's...
Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCstm), today announced the appointment of Simona Skerjanec, M.Pharm, MBA to its board of...
Agreement with FDA reached on key elements to move forward with our international Phase 3 clinical trial programAgreement also reached with FDA on complete non-clinical and clinical development plan for filing of a New Drug Application for marketing...
Mural Health, a patient-first clinical trial technology company, was named "Most Innovative Start-up" at the 2024 Citeline Awards. Hosted by Citeline (a leading provider of business intelligence in the pharmaceutical and medtech markets), this award...
Inimmune, a leading clinical stage biotech company focused on the development of novel vaccine adjuvants, immunotherapies and delivery systems, announced today the top line results from its Phase 1b Multiple Ascending Dose (MAD) study of INI-2004 in...
The new Affordable Dentures & Implants practice in Greensboro, North Carolina, located at 1218 Bridford Parkway, Unit S, is now open. The practice joins the nation's largest provider network of dental practices ? supported by Affordable Care ?...